USA Track and Field appears to confirmed that Sha Carri Richardson has returned an Adverse Analytical Finding for cannabis from last month’s US Trials and will likely miss the Olympic Games this summer.

Richardson won the 100m for women at the US trials in 10.86 setting a potential blockbuster clash with the world’s best female sprinters, especially two-time Olympic champion, Shelly-Ann Fraser-Pryce, who is gunning for an unprecedented third Olympic 100m title.

However, following the unfortunate news that broke last yesterday, the USATF issued a brief statement saying, “Sha ‘Carri Richardson’s situation is incredibly unfortunate and devastating for everyone involved.

“Athlete health and well-being continue to be one of USATF’s most critical priorities and we will work with Sha ‘Carri to ensure she has ample resources to overcome any mental health challenges now and in the future.”

According to reports, Richardson could face a four-year ban. However, if she can establish that the use of the drug was used outside of competition and was not intended to enhance performance, she could have the ban reduced to three months. It has also been reported that should she agree to undertake a treatment program, the ban could be reduced further.

One report claims that if Richardson’s ban is substantially reduced, she could still be available to compete in the 4x100m relay at the Olympic Games if selected.

However, Jenna Prandini, who was fourth at the US trials and Gabby Thomas, has been entered for the 100m in Tokyo.